Are there any additional eligibility criteria for intravenous thrombolysis in patients with borderzone (watershed) infarction, given that it may result from hypoperfusion rather than arterial thrombus?

Borderzone Infarction and IV Thrombolysis: No Additional Requirements Beyond Standard Eligibility

Borderzone (watershed) infarction does NOT require any additional eligibility criteria beyond the standard IV thrombolysis protocol—the same inclusion/exclusion criteria apply regardless of infarct location or presumed mechanism. 1

Standard Eligibility Applies Universally

The 2018 AHA/ASA guidelines make no distinction based on stroke mechanism or anatomical location when determining IV alteplase eligibility. 1 The standard criteria include:

• Time window: Treatment within 3 hours (Class I) or 3-4.5 hours (Class I, with additional exclusions) from symptom onset
• Standard contraindications: Intracranial hemorrhage, bleeding diathesis, severe uncontrolled hypertension (>185/110 mmHg), recent surgery, etc.
• Clinical assessment: Disabling neurological deficit on examination

Why Mechanism Doesn't Change Eligibility

Your concern about hypoperfusion versus thrombotic mechanism is clinically understandable but practically irrelevant for thrombolysis decisions. Here's why:

In real-time acute stroke management, you cannot definitively determine mechanism at the bedside. 2 Watershed strokes result from both hemodynamic compromise AND arterial embolism—often simultaneously. 2 The 2023 review explicitly states that "it is often difficult to say which mechanisms are fully responsible for producing cerebral ischemic lesions." 2

The benefit of IV alteplase is mechanism-agnostic. The landmark trials establishing thrombolysis efficacy included patients with various stroke mechanisms and locations. 1 The guidelines emphasize that "benefit of IV alteplase is well established for adult patients with disabling stroke symptoms regardless of age and stroke severity." 1

Critical Pitfalls to Avoid

Do not delay or withhold thrombolysis while attempting to determine stroke mechanism. Time is brain—every 15-minute delay reduces the probability of good outcome. The standard evaluation (history, exam, non-contrast CT, basic labs) is sufficient. 1

Do not assume borderzone location means "low-flow only" pathophysiology. Even if hypoperfusion contributed, there may still be thromboembolic material amenable to lysis. 2 Withholding thrombolysis based on anatomical pattern alone would be inappropriate.

Address the underlying cause AFTER acute reperfusion therapy. If you suspect hemodynamic compromise (severe carotid stenosis, cardiac dysfunction), this requires investigation and management—but not before administering time-sensitive thrombolysis to an otherwise eligible patient. 3

Special Consideration: Refractory Hypotension

One scenario where borderzone location should heighten your clinical suspicion: If the patient has persistent, unexplained hypotension, aggressively investigate cardiac causes (including occult coronary disease) even with normal troponin. 3 However, this doesn't change thrombolysis eligibility—it changes your parallel workup and post-thrombolysis management.

The 2026 case report demonstrates that critical coronary stenosis can drive ongoing watershed infarction through refractory hypotension. 3 In such cases, addressing the hemodynamic cause (coronary revascularization, fluid resuscitation) becomes essential, but this is complementary to—not a replacement for—standard stroke reperfusion therapy.

The Bottom Line Algorithm

1. Patient presents with acute ischemic stroke symptoms → Activate stroke protocol
2. Obtain non-contrast CT, basic labs, vital signs → Rule out hemorrhage and standard contraindications
3. Imaging shows borderzone infarction → This changes NOTHING about thrombolysis eligibility
4. Apply standard eligibility criteria from Table 6 of AHA/ASA guidelines 1
5. If eligible and within time window → Administer IV alteplase (0.9 mg/kg)
6. Simultaneously investigate potential hemodynamic causes → Carotid imaging, cardiac evaluation, blood pressure optimization
7. Post-thrombolysis management → Address underlying mechanism to prevent recurrence

The anatomical pattern of infarction is diagnostically interesting but therapeutically irrelevant for acute thrombolysis decisions. 1